ArticleThe patient2021
How Do Respondents Interpret and View the EQ-VAS? A Qualitative Study of Three Asian Populations.
Article in The patient, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Exploration of visual analogue scale versions with the EQ-HWB-9 to measure health, social care, and carer-related quality of life: a VASt landscape.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Challenges with interviewer administration of EQ-5D questionnaires in a large-scale population survey in China: a qualitative analysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Psychometric performance of the experimental EQ-HWB-9 and EQ-5D-5L in the general Chinese population.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Anxiety and depression may amplify self-reported physical health problems: evidence from EQ-5D-5L data.Health and quality of life outcomes · 2026Article
- Exploration of health-related quality of life, anxiety and depression in antineutrophil cytoplasmic antibody-associated vasculitis.Rheumatology (Oxford, England) · 2025Article
- Exploring the origin and conceptual framework of the EQ VAS.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Review
- Comparison of the measurement properties and consistency between the EQ-5D-3L and EQ-5D-Y-3L in adolescents aged 15-17 in China.Health and quality of life outcomes · 2024Article
- The Limitations of EQ-5D as a Clinical Outcome Assessment Tool.The patient · 2024Article
- Acceptability of the routine use and collection of a generic patient reported outcome measure from the perspective of healthcare staff: a qualitative study.Journal of patient-reported outcomes · 2023Article
- Total Knee Arthroplasty in Patients with Primary Sjögren's Syndrome: A Retrospective Case-Control Study Matched Patients without Rheumatic Diseases.Journal of clinical medicine · 2022Article
- 'Like holding the axe on who should live or not': adolescents' and adults' perceptions of valuing children's health states using a standardised valuation protocol for the EQ-5D-Y-3L.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022Article
- Perceptions of the General Public About Health-related Quality of Life and the EQ-5D Questionnaire: A Qualitative Study in Korea.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022Article
- Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.The European journal of health economics : HEPAC : health economics in prevention and care · 2021Article
- Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.The European journal of health economics : HEPAC : health economics in prevention and care · 2021Article
- The pathways from perceived discrimination to self-rated health among the Chinese diaspora during the COVID-19 pandemic: investigation of the roles of depression, anxiety, and social support.International journal for equity in health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to understand how respondents from three Asian countries interpret and perceive the EuroQol Visual Analogue Scale (EQ-VAS).
methodData were from a project that aimed to examine the cultural appropriateness of EQ-5D in Asia. Members of the general public from China, Japan, and Singapore were interviewed one-to-one in their preferred languages. Open-ended questions (e.g. What does "best imaginable health" mean to you?) were used to elicit participants' interpretation of the labels of EQ-VAS. How the scale could be improved was also probed. Thematic and content analyses were performed separately for each country before pooling for comparison.
resultsSixty Chinese, 24 Japanese, and 60 Singaporeans were interviewed. Interpretations of the label "Best Imaginable Health" varied among the participants. Interestingly, some participants indicated that "Best Imaginable Health" is unachievable. Interpretations for "Worst Imaginable Health" also varied, with participants referring primarily to one of three themes, namely, "death," "disease," and "disability." There were different opinions as to what changes in health would correspond to a 5- to 10-point change on the EQ-VAS. While participants opined that EQ-VAS is easy to understand, some criticized it for being too granular and that scale labels are open to interpretation. Findings from the three countries were similar.
conclusionIt appears that interpretations of the EQ-VAS vary across Asian respondents. Future studies should investigate whether the variations are associated with any respondent characteristics and whether the EQ-VAS could be modified to achieve better respondent acceptance.
Indexed as
Identifiers
32944897What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.